Want to track EPRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Eupraxia Pharmaceuticals Inc. (EPRX) Statistics
Valuation metrics
Market Cap 213.6M
Enterprise value 153.07M
Trailing P/E (ttm) -5.55
Forward P/E -
PEG ratio 0.14
Price/Sales (ttm) -
Price/Book (mrq) 2.4
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.43
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 529.2K
Average volume (90 days) 328.43K
Price summary
52-Week low 5.04
52-Week high 9.32
Beta -
50-Day moving average 6.28
200-Day moving average 7.56
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.31%
Return on equity -0.54%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.78
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.45
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 19.3%
Book value per share (mrq) 2.4
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
